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OBJECTIVE: The objective of this study was to present special clinical and laboratory features of 294 cases of mushroom poisoning. 
MATERIALS AND METHODS: In this retrospective study, 294 patients admitted to the Pediatric and Adult Emergency, Internal 
Medicine and ICU Departments of Cumhuriyet University Hospital were investigated. 
RESULTS: Of 294 patients between the ages of 3 and 72 (28.97 ± 19.32), 173 were female, 121 were male and 90 were under 
the age of 16 years. One hundred seventy-three patients (58.8%) had consumed the mushrooms in the early summer. The onset of 
mushroom toxicity symptoms was divided into early (within 6 h after ingestion) and delayed (6 h to 20 d). Two hundred eighty-
eight patients (97.9%) and six (2.1%) patients had early and delayed toxicity symptoms, respectively. The onset of symptoms was 
within two hours for 101 patients (34.3%). The most common first-noticed symptoms were in the gastrointestinal system. The 
patients were discharged within one to ten days. Three patients suffering from poisoning caused by wild mushrooms died from 
fulminant hepatic failure.
CONCLUSION: Education of the public about the consumption of mushrooms and education of health personnel working in health 
centers regarding early treatment and transfer to hospitals with appropriate facilities are important for decreasing the mortality.
KEYWORDS: Mushroom; Poisoning; Emergency service; Intensive care unit.
INTRODUCTION
Various types of wild mushrooms grow in forests 
and meadows, and it is common for the local population 
to consume them.1 It is estimated that there are over 
5000 species of mushrooms worldwide. Only 20-25% 
of mushrooms have been named, and 3% of these are 
poisonous.2 Previous experience and observation make 
it possible to discriminate between poisonous and non-
poisonous mushrooms.1 Mushroom poisoning constitutes 
the main portion of plant toxicities in Turkey. In addition 
to occurring in rural areas, gathering of mushrooms is a 
habit in Istanbul among villagers who have moved to the 
city and settled in the vicinity of a forest.3 During the four-
year period from 1994 to 1998 in Sivas, Turkey, mushroom 
poisoning represented 10.9% of the different analyzed 
poisonings.4 However, these cases were not analyzed 
toxicologically.
Depending on the type of mushroom, the adverse 
effects range from mild gastrointestinal (GI) symptoms to 
major cytotoxic effects resulting in organ failure and death. 
Toxicity may also vary depending on the amount and age 
of the mushroom, the season, the geographic location and 
the way in which the mushroom was prepared prior to 
ingestion. Consumption of poisonous mushrooms can cause 
various types of reactions, such as allergic gastroenteritis, 
psychological relaxation and fatal liver intoxication.1,5,6 
Mushroom poisoning occurs among four main groups 
of individuals: young children who ingest mushrooms 
inadvertently, wild-mushroom foragers, individuals 
attempting suicide or homicide and individuals looking for a 
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hallucinatory high. Identification of the ingested mushroom 
can be difficult and time consuming. In all cases, treatment 
should be directed by the patient’s symptoms rather than by 
attempts at mushroom identification.6
Today, emergency department physicians have increasing 
occasions to treat mushroom poisoning. Interest in eating 
mushrooms has risen dramatically in recent years as part 
of the back-to-nature and organic food movement. In 
addition, some people are eating certain mushrooms for 
their hallucinogenic components, leading to an increase in 
mushroom poisonings.7 
This study’s aim was to determine the demographic and 
clinical features of adult and pediatric patients who were 
admitted to the hospital (ED) due to mushroom poisoning, 
and to emphasize the significance of mushroom poisoning. 
We contribute one of the largest series to be applied to the 
same hospital concerning mushroom poisoning, which 
has been seen frequently in developing countries and will 
increase in developed countries due to the rise of natural 
nutrition. Furthermore, to establish this study as the largest 
serial study concerning mushroom poisoning in Turkey, 
we will present extensive information about mushroom 
poisonings in our country.
MATERIALS AND METHODS
A retrospective descriptive/epidemiologic study was 
designed, and all patients with mushroom poisoning 
admitted to the Pediatric and Adult Emergency, Internal 
Medicine and ICU departments in the Cumhuriyet 
University Hospital in Sivas between 2000 and 2007 were 
studied. Two hundred ninety-four patients with mushroom 
poisoning were included in the study. We collected data on 
the season and location where the mushrooms were picked, 
method of cooking, symptoms, onset time for symptoms, 
laboratory findings, type of treatment administered and 
results of therapies. The laboratory evaluation included 
blood glucose, bilirubin, liver function, complete blood cell 
count, coagulation profile, electrolyte and renal function 
tests. Diagnosis was made according to the physical features 
of the mushrooms, time of appearance of symptoms, clinical 
conditions of the patients and laboratory parameters. 
The mushrooms toxins could not be analyzed. The onset 
times of mushroom toxicity symptoms were divided into 
early (within 6 h after ingestion) and delayed (6 h to 20 
d). Patients with early symptoms were treated by stomach 
irrigation, the maintenance of the fluid-electrolyte balance, 
forced diuresis and the administration of activated charcoal, 
whereas patients with severe toxicity symptoms were treated 
by adding crystallized penicillin. In patients with fulminant 
hepatic failure, maintenance therapy was given, but liver 
transplantation could not be performed. Data are presented 
as the mean (SD) or percentage. 
All data were analyzed with SPSS software, version 16.0. 
A detailed multiple-variable database was formed. Statistical 
comparisons were carried out using the Mann-Whitney 
U-test and Student’s t -test. The Pearson test was used to 
evaluate correlations among variables. P values of 0.05 or 
less were considered to be statistically significant.
RESULTS
Two hundred ninety-four patients aged between three 
and seventy-two years (28.97 ± 19.32) were studied. Of 
these, 204 (69.4) were adults, and 90 (30.6%) were in 
the pediatric age group. In the adult group, 121 patients 
were female, and 83 were male. In the pediatric group, 52 
patients were female, and 38 were male. It was established 
that 173 (58.8%) patients had consumed the mushrooms 
in the early summer, 84 (28.6%) in the spring, 22 (7.5%) 
in the autumn and 15 (5.1%) in the winter. Two hundred 
seventy-six (93.8%) patients had foraged for the mushrooms 
in nature (hills, riverbanks, fields), and eighteen (6.2%) had 
bought cultivated mushrooms. The methods of cooking were 
as follows: the mushrooms were grilled by 112 (38.1%) 
patients, roasted by 78 (26.5 %), cooked into the meal by 
45 (15.3%) and consumed uncooked by 59 (20.1%). In 
total, 112 (38.1%) patients were seen in the emergency care 
unit, 59 (20.1%) in the internal service, 33 (11.2%) in the 
intensive care unit and 90 (30.6%) in the pediatric service. 
Laboratory abnormalities were found in 112 (38.1%) 
patients and included hematological abnormalities 
(leukocytosis, thrombocytopenia, prolonged prothrombin 
time), elevated liver enzymes, hematuria, glucosuria, 
impaired renal functions, hyponatremia, hypernatremia and 
hypoglycemia (Table 1). 
Two hundred eighty-eight (97.9%) patients had early 
and six (2.1%) had delayed toxicity symptoms. The onset 
of symptoms was within two hours for 101 (34.3%) 
patients. The signs and symptoms included cardiovascular, 
gastrointestinal and central nervous system symptoms (Table 
2). In both adult and pediatric groups, the most common 
first symptom was nausea and vomiting (84.8% and 78.8%, 
respectively) (Table 3).
One hundred seventy-seven (60.2%) patients were treated 
by stomach irrigation and the administration of activated 
charcoal. One hundred eleven (37.7%) patients who had 
severe clinical manifestations were treated with stomach 
irrigation as well as administration of activated charcoal and 
penicillin G. Six patients (2.1%) rejected therapy.
Four patients were pregnant. Neither the mothers nor 
the fetuses showed any problems. All of the patients were 
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discharged within one to ten days. However, three patients 
(child=1, adult=2) who consumed raw mushrooms and were 
treated in the ICU died due to acute hepatic failure (Table 
4). The mortality rate was 1.02%. There was a significant 
(p<0.001) relationship between mortality, hepatic failure and 
consuming raw mushrooms.
DISCUSSION
Mushroom poisoning presents a major health risk in 
rural areas. It is estimated that there are over 5000 species 
of mushroom worldwide.2 Foraging for wild mushrooms is 
popular in Europe, the United States and the Far East.8-12 The 
exact identification of mushroom species can be difficult. 
Substantial morphologic variations can occur in the same 
mushroom species depending on the season, geographic 
location and maturity of the fungus. Most ingested 
mushrooms are either nontoxic or only gastrointestinal 
irritants, resulting in mild to moderate toxic effects.13 
The pathogenicity of mushrooms depends on 
cyclopeptide toxins. The type of mushroom is unknown in 
>90% of cases of digestion.5,14 Amatoxins, which account 
for 90% of fatal mushroom poisonings, have their most 
significant impact on the liver.15 
Mushroom poisonings occur every year between June 
and December.16 A study performed in Japan reported 
that mushroom poisoning happened most frequently in 
September and October.17 A similar study performed in 
İran reported that mushroom poisoning usually happened in 
autumn and spring.18 Unluoglu et al. reported that mushroom 
poisoning cases were seen in the spring or early summer.19 
Ergüven et al. reported that mushroom poisoning cases were 
seen in the autumn.20 Another study performed in Turkey 
Table 1 - Laboratory data.
Variables Adult (n=204) Pediatric (n=90)
Elevated WBC, (>12000 U/L) 37 (18.1) 34 (37.8)
Thrombocytopenia, (<100000 U/L) 2 (0.9) 1 (1.1)
PT (s), (> 17) 7 (3.4) 4 (4.4)
PTT (s), > 40 6 (2.9) 4 (4.4)
ALT (U/L), 40-100
                  100-400
                 > 400
11 (5.4)
3 (1.5)
3 (1.5)
1 (1.1)
 1 (1.1)
1 (1.1)
AST (U/L), 40-100
                100-400
                > 400
15 (7.4)
3 (1.5)
3 (1.5)
1 (1.1)
0 (0)
1 (1.1)
Bilirubin Total (mg/dl), (> 1) 5 (2.5) 1 (1.1)
BUN (mg/dl), (40-100) 6 (2.9) 1 (1.1)
Creatinine (mg/dl), 1-3
                               > 3
17 (8.3)
1 (0.5)
1 (1.1)
0 (0)
Microscopic hematuria, (>50/mm3 
erythrocyte)
4 (1.9) 0 (0)
Hyponatremia 10 (4.9) 4 (4.4)
Hypernatremia 2 (0.9) 0 (0)
Hyperglycemia (> 200 mg/dl ) 6 (2.9) 6 (6.6)
Glucosuria 5 (2.5) 0 (0)
ALT: Alanine aminotransferase,   AST:Aspartate aminotransferase  
PT:Protrombintime  
PTT:Activated Parsiyel tromboplastin time  BUN:Blood Urea Nitrogen
Table 2 - Signs and symptoms of poisoning. 
Variables Adult (n=204) Pediatric (n=90)
Nausea/vomiting 173 (84.8) 71 (78.8)
Fatigue 78 (38.2) 0 (0)
Abdominal pain 65 (31.9) 16 (17.8)
Dizziness 62 (30.4) 21 (23.3)
Diarrhea 52 (25.5) 10 (11.1)
Headache 35 (17.29) 5 (5.5)
Loss of consciousness 34 (16.6) 20 (22.2)
Bradycardia 27 (13.2) 1 (1.1)
Hyperthermia (> 370C) 20 (9.8) 0 (0)
Hypotension (< 80 mmHg / systolic)† 17 (8.3) 1 (1.1)
Tachycardia 15 (7.4) 18 (20)
Mouth drying 14 (6.9) 1 (1.1)
Myosis 13 (6.4) 0 (0)
Blurred vision 12 (5.9) 4 (4.4)
Dyspnea 10 (4.9) 0 (0)
Tremor 9 (4.4) 2 (2.2)
Mydriasis* 8 (3.9) 0 (0)
Pruritus 7 (3.4) 0 (0)
Urticaria 6 (2.9) 0 (0)
Sweating 6 (2.9) 2 (2.2)
Agitation 5 (2.5) 6 (6.6)
Convulsion 5 (2.5) 2 (2.2) 
Hypertension (> 160 mmHg / systolic) 4 (1.9) 0 (0)
Arrhythmia 3 (1.5) 0 (0)
Absence of light reflex 2 (0.9) 0 (0)
Cyanosis 2 (0.9) 0 (0)
Tongue edema 2 (0.9) 0 (0)
Diplopia 1 (0.5) 1 (1.1)
Nosebleed 0 (0) 1 (1.1)
*After atropine for two patients. †Systolic blood pressure < 60 mmHg for 
three patients
Table 3 - First symptoms of poisoning. 
Variables Adult (n=204) Pediatric (n=90)
Nausea/vomiting, n (%) 131 (64.2) 67 (74.4)
Dizziness, n (%) 22 (9.8) 11 (12.2)
Abdominal pain, n (%) 18 (8.8) 4 (4.4)
Blurred vision, n (%) 8 (3.9) 2 (2.2)
Headache, n (%) 8 (3.9) 0 (0)
Loss of consciousness, n (%) 7 (3.4) 3 (3.3)
Diarrhea, n (%) 3 (1.5) 2 (2.2)
Urticaria, n (%) 6 (2.9) 0 (0)
Convulsion, n (%) 0 (0) 1 (1.1)
Pruritus 1 (0.5) 0 (0)
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reported that mushroom poisoning usually happened in 
October and November.21
In our study, 58.8% of the patients consumed the 
mushrooms in the early summertime. While the winter is 
very long and the rains start in May and June, mushroom 
collecting is increased during these months, and mushroom 
poisonings were seen at this time in Sivas. A seasonal 
variation was also seen in the present study that is consistent 
with the characteristics of the seasons, i.e., it rains during the 
spring, when mushrooms are prevalent.
Mushroom poisoning is caused not only by toxic 
mushrooms (true intoxications) but also, under certain 
conditions, by edible mushrooms (false intoxications and 
pseudo-intoxications).22 In our study, most of the mushroom 
poisonings were due to the consumption of foraged 
mushrooms, but 6.2% arose from commercially cultivated 
mushrooms. In another study, 5.6% of the patients were 
poisoned with cultivated mushrooms.19 A two-year survey 
conducted by the Food and Drug Administration showed that 
21% of cultivated mushrooms were contaminated with toxic 
look–alike species.23 
Cultivated mushroom poisoning did not result in 
adverse outcomes in our study. This shows that sanitation 
and hygienic conditions are inadequate during mushroom 
production. 
Many preparation methods were used for the mushrooms 
before ingestion. In our study, grilling (38.1%) and roasting 
(26.5%) of the mushrooms were the most common. The 
toxicity may vary based on the amount ingested and the way 
in which the mushroom was prepared prior to ingestion. 
The cooking of wild mushrooms was relatively safe. Raw 
mushroom ingestion was very dangerous. In our study, 
the three patients who died from mushroom poisoning 
had ingested the mushrooms raw. Children are especially 
susceptible to this risky endeavor. They can easily find 
mushrooms in nature and eat them without cooking. Families 
must be careful to prevent accidental mushroom ingestion 
among children.
Clinically, mushroom toxicity is divided into early 
(within 6 h after ingestion) and delayed (6 h to 20 d).5 In 
our study, most of the patients (97.9%) had early toxicity 
symptoms. Only 2.1% of the patients had delayed toxicity 
symptoms. The most common first-noticed symptoms 
were gastrointestinal. A total of 37.7% of the patients had 
laboratory abnormalities. Alterations in hematological 
parameters and elevated transaminase levels were the most 
common laboratory findings. A considerable portion of 
amatoxin is taken up by hepatocytes, excreted into the bile 
and reabsorbed by the enterohepatic cycle.24,25 The amatoxins 
bind to RNA polymerase II and thus inhibit the hepatic 
formation of mRNA.26 As a result of this, Amanita species 
cause increases of AST(Aspartate aminotransferase) and 
ALT(Alanine aminotransferase) levels in the serum.27 
Pajoumand et al. showed increases in ALT and AST 
levels in 17 of 25 patients.18 In another study examining 
6317 cases, an increase in transaminase levels was reported 
for 0.5% of the patients.28 In the present study, 8.1% of the 
cases were found to have increased levels of AST and ALT. 
The patients who died had very high AST and ALT levels, 
with AST values between 2075–3464 U/L and ALT values 
between 2345–4048 U/L. As the AST and ALT values rose, 
hepatic coma followed. There was a significant relationship 
between mortality and liver enzyme levels (AST, ALT). This 
indicates that liver enzyme levels (AST, ALT) are a good 
prognostic marker of mushroom poisoning or an indication 
for liver transplantation.
Because the goal of the total prevention of mushroom 
poisoning is likely never to be reached, it is important for 
clinicians to focus on diagnosis and treatment. The diagnosis 
of mushroom poisoning must at least be considered in 
patients with appropriate symptoms. The most common 
toxic symptoms recorded in this study’s subjects, including 
nausea, vomiting, fatigue, abdominal pain, dizziness, 
diarrhea, headache and loss of consciousness, have also been 
reported in the literature.29,30  
Most patients present with gastrointestinal symptoms. 
It is important to establish the latency period of symptoms 
after ingestion. Late toxicities (symptom onset >6 hrs after 
ingestion) are life-threatening due to liver and renal failure. 
Patients who have jaundice after an acute gastrointestinal 
episode are suspected to be poisoned with amatoxins. 
Symptoms of mushroom poisonings with amatoxins begin 
Table 4 - Laboratory parameters of deceased patients.
Age (y) ALT (U/L) AST (U/L) PT (s) PTT (s) Platelet (U/L) Bilirubin (mg/
dl)
BUN (mg/dl) Creatinine 
(mg/dl)
Case 1 45 2075 2345 50 62 16900 10.4 58 3.2
Case 2 50 2754 2890 68 56 61900 12.8 42 3
Case 3 13 3464 4048 120 94 32000 18.4 25 1.3
ALT: Alanine aminotransferase,   AST:Aspartate aminotransferase  PT:Protrombintime  
PTT:Activated Parsiyel tromboplastin time  BUN:Blood Urea Nitrogen
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at six to twenty-four hours after the initial ingestion of the 
mushroom.31,32 In our study, most of the mushroom-poisoned 
patients had early toxicity symptoms. 
In total, 10.2% of our patients were discharged after 24 
hours of admission, while 49.7% required hospitalization 
for 72 hours. According to the patients’ symptoms and 
doctors’ decisions, the patients were observed in the hospital 
for 24 hours to 72 hours. The patients who had no clinical 
manifestations or laboratory abnormalities were discharged 
from the hospital after the 24 hours of observation. Only 
11.2% of the patients required intensive care unit admission. 
The patients who had delayed toxicity symptoms were 
required to undergo observation in the intensive care unit. 
The patients who had moderate clinical and laboratory 
findings were observed in the emergency observation unit. If 
a patient had no clinical and laboratory findings in 24 hours, 
they could be safely discharged from the hospital. 
The patients who had histories of wild mushroom 
consumption were treated. The patients who had mild 
clinical symptoms were treated by stomach irrigation and 
the administration of activated charcoal, while those who 
had severe clinical manifestations were treated with stomach 
irrigation and the administration of activated charcoal in 
addition to penicillin G. The patients who had clinical 
symptoms from the cultivated mushrooms were treated 
symptomatically. 
In this study, 294 patients with mushrooms poisoning, 3 
of whom died (one child, two adults), were admitted to the 
Cumhuriyet University Hospital of the Faculty of Medicine 
in Sivas between 2000 and 2007. The mortality rate in this 
study was 1.02%. Unluoglu et al. reported a mortality rate 
of 2.8%.19 In another study in Turkey the mortality rate 
was 17.9%.20 In a study in Istanbul the mortality rate was 
21.4%.20 The mortality rate of mushroom poisoning in 
Iran, one of our neighboring countries, was 12%.18 The low 
mortality rate in our study was due to early presentation 
to the hospital, early treatment by hemoperfusion and 
intoxication by species other than Amanita. An additional 
reason could be that the wild mushrooms in our region were 
less poisonous.
Mushroom poisoning is a public health problem. 
People and health care providers must be educated about 
this poison. The species of mushrooms are numerous, and 
there are various clinical presentations depending on the 
ingested species. There are no guidelines about the treatment 
of mushroom toxicity in the emergency department, so 
diagnosis and treatment must be based on the history of 
ingestion and associated clinical presentations. Patients 
showing delayed toxicity symptoms should be observed 
in intensive care units. Despite treatment, the prognosis 
can be mortal. These types of patients must be transferred 
immediately to hospitals where liver transplantations can 
be performed. Children are a high-risk group for wild and 
uncooked mushroom poisonings.
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